(Q46886466)

26 December 2017

title

Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy (English)

1 reference

26 December 2017

0 references

6

R F Tyndale

1 reference

26 December 2017

author name string

V Malaiyandi

1

1 reference

26 December 2017

C Lerman

2

1 reference

26 December 2017

N L Benowitz

3

1 reference

26 December 2017

C Jepson

4

1 reference

26 December 2017

F Patterson

5

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

26 December 2017

published in

Molecular Psychiatry

1 reference

26 December 2017

volume

11

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

400-409

1 reference

26 December 2017

Metabolism of nicotine to cotinine studied by a dual stable isotope method.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Whole deletion of CYP2A6 gene (CYP2A6AST;4C) and smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Genetic variation of CYP2A6, smoking, and risk of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Nicotine replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Serum nicotine and cotinine levels during nicotine-patch therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

CYP2A6 genetic variation and potential consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

High-dose nicotine patch therapy. Percentage of replacement and smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A6*9).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Genotyping human CYP2A6 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Three haplotypes associated with CYP2A6 phenotypes in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Metabolism and disposition kinetics of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Smoking cessation by socioeconomic status and marital status: the contribution of smoking behavior and family background

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Predictors of 6-month tobacco abstinence among 1224 cigarette smokers treated for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Perceived risks and benefits of smoking cessation: gender-specific predictors of motivation and treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Smoking cessation in women. Special considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Unaided smoking cessation and predictors of failure to quit in a community sample: effects of gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

The genetic determinants of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Elucidating the role of genetic factors in smoking behavior and nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Genetics of alcohol and tobacco use in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Effects of different nicotine replacement therapies on postcessation psychological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Nicotine metabolite ratio as a predictor of cigarette consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Nicotine blood levels and subjective craving for cigarettes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Current pharmacological treatments for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

7 January 2021

Nicotine and cotinine replacement when nicotine nasal spray is used to quit smoking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

7 January 2021

The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

7 January 2021

Circadian blood nicotine concentrations during cigarette smoking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

7 January 2021

Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

7 January 2021

The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001794

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001794

1 reference

26 December 2017

Dimensions Publication ID

1014442944

0 references

1 reference

26 December 2017